Dr. Owen J. Halloran, MD

Dr. Halloran practices at Samaritan Hospital in Troy, New York, part of Trinity Health.

Dr. Halloran's NPI, 1538221015, was assigned on December 14, 2006. Dr. Halloran graduated from University of Rochester School of Medicine and Dentistry in 2005. Dr. Halloran holds New York license 270594.

Dr. Halloran's primary practice is Samaritan Hospital, at 2215 Burdett Avenue, Troy, NY 12180 in Rensselaer County. The practice phone is (518) 427-3402.

Dr. Halloran's primary practice is Samaritan Hospital in Troy, New York, part of Trinity Health. Dr. Halloran is also affiliated with Albany Medical Center. The medical group on file is Albany Med EmUrgentCare. Dmand AI also links Dr. Halloran to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Halloran practices, 3 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Halloran's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dmand AI has Dr. Halloran's licenses on file in 3 states: New York, Maryland and Pennsylvania.

CMS data shows 238 Medicare services from Dr. Halloran across 13 procedure codes in 2024, for 329 Medicare patients. Medicare paid $17,030 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 329 Medicare patients who saw Dr. Halloran in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Halloran's median patient age at 57, with 61% women.

In 2019, Dr. Halloran wrote 560 Medicare Part D claims. They cover 3 drugs, with $89,656 in total drug cost. In 2018, CMS named 1,891 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 40 out of 100 for Dr. Halloran for performance year 2024, reported as part of a group. Dr. Halloran accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Dr. Halloran from 1 drug or device company from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $96.

Dr. Halloran graduated from University of Rochester School of Medicine and Dentistry in 2005.